Posts

Showing posts with the label Primary Cell Culture Market

Global Primary Cell Culture Market Analysis & Trends 2024-2030

  Primary Cell Culture Industry Overview The global primary cell culture market size is expected to reach USD 11.59 billion by 2030, expanding at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.   Moreover, the field of regenerative medicine aims to replace or repair damaged tissues an...

Primary Cell Culture Market expected to expand at a CAGR of 11.6% from 2021 to 2028

  Primary Cell Culture Industry Overview The global  primary cell culture market  size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. The market growth is owing to several factors such as advancement in genetic engineering, rising demand for regenerative medicines, and robust funding for cellular therapies development.   Primary Cell Culture Market Segmentation Grand View Research has segmented the global primary cell culture market based on product, separation methods, cell type, application, and region:   Based on the Product Insights, the market is segmented into Primary Cells, Reagents and Supplements and Media. The reagents and supplements segment dominated the market for primary cell culture and accounted for the largest revenue share of 34.0% in 2020. In addition, the development of innovative products such as growth...